期刊文献+

脓毒症的早期诊断相关研究进展 被引量:37

Research progress in early diagnosis of sepsis
下载PDF
导出
摘要 脓毒症是由潜在或已知感染等因素引起的全身炎症反应,进展后可出现感染性休克及多器官功能障碍而危及生命。脓毒症不是一个独立的疾病,而是一个复杂的、动态的、一系列生理功能和代谢紊乱的临床综合征。脓毒症休克是感染性疾病炎性反应发展的终末阶段,早期诊断对患者的治疗及预后起到非常关键的作用。然而,目前脓毒症的诊断仍无有效的金标准,没有高敏感度和特异度的单一生物标志物。本文复习了3次脓毒症诊断共识的区别及联系,综述脓毒症及脓毒症休克的早期诊断相关研究进展,以加深对脓毒症的认识。 Sepsis is a systemic inflammatory response caused by infection or potential infective factors.Severe patients can suffer from septic shock and multiple organ dysfunction. Sepsis is a dynamic clinical syndrome with a series of physiological dysfunction and metabolic disorders. Septic shock is the late stage of inflammatory reaction in patients with infectious disease. Early diagnosis of sepsis plays an important role in the treatment and prognosis of disease. However, there is still no diagnostic standards, high-sensitivity and high-specificity biomarkers. This article summarized 3 versions of consensus on sepsis diagnosis and early diagnosis of sepsis and septic shock.
作者 谭乐明 杨成 周水英 杨旭凯 蔡高平 董永超 王养民 Tan Leming;Yang Cheng;Zhou Shuiying;Yang Xukai;Cai Gaoping;Dong Yongchao;Wang Yangmin(Clinical Medical College,Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China;Fourth Group of Students,College of Basic Medical Sciences,Air Force Military Medical University,Xi'an 710032,China;the First Clinical Medical College of Wuhan University,Wuhan 430060,China;Department of Urology,the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army,Lanzhou 730050,China)
出处 《中国医药》 2020年第5期796-800,共5页 China Medicine
基金 甘肃省自然科学基金(18JR3RA405) 甘肃省科技支撑计划(1504FKCA101)。
关键词 脓毒症 脓毒症休克前期 早期诊断 Sepsis Pre-shock sepsis Early diagnosis
  • 相关文献

参考文献9

二级参考文献86

  • 1赵玉玲.降钙素原对脓毒症早期诊断的临床意义[J].检验医学,2006,21(4):431-431. 被引量:37
  • 2Cheng B, Xie G, Yao S, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med ,2007,35 : 2538-2546.
  • 3Levy MM, Dellinger RP, Townsebd SR, et al. The Surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med, 2010,36:222-231.
  • 4Heidecke CD, Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intra-abdominal infection. Am J Surg, 1999, 178: 288-292.
  • 5Hotchkiss RS, Tinsley KW, Swanson PE, et al. Depletion of dendritic cells, bntnot maerophages, in patients with sepsis. J Immunol, 2002,168 : 2493-2500.
  • 6Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med, 2006, 32 : 1175-1183.
  • 7Hotchkiss RS, Coopersmith CM, McDunn JE, et al. The sepsis seesaw: tilting toward immunosuppression. Nat Med, 2009, 15 : 496-497.
  • 8Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA, 2009, 301 : 2445- 2452.
  • 9Tidswell M, Tillis W, Lamsa SP, et al. Phase 2 trial of tetrasodium ( E5564 ), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med, 2010,38:72-83.
  • 10Zhang Y, Chen H, Li Y, et al. Thymosinoq- and ulinastatin- based immunomodulatory strategy for sepsis arising from intra- abdominal infection due to carbapenem-resistant bacteria. J Infecti Dis, 2008,198:723-730.

共引文献202

同被引文献401

引证文献37

二级引证文献155

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部